Q1 EPS Forecast for ArriVent BioPharma Boosted by Analyst
Investment analysts at HC Wainwright raised their Q1 2025 EPS estimates for ArriVent BioPharma in a report issued on Wednesday, January 22nd. HC Wainwright analyst R. Burns now anticipates that the ...
What is Leerink Partnrs’ Forecast for BEAM FY2024 Earnings?
Equities research analysts at Leerink Partnrs boosted their FY2024 earnings estimates for Beam Therapeutics in a research note issued to investors on Wednesday, January 22nd. Leerink Partnrs analyst M ...